Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals

被引：0
|
作者：
Kappelhoff, BS
Huitema, ADR
Yalvaç, Z
Prins, JM
Beijnen, JH
机构：
[1] Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [41] Neurosyphilis in a clinical cohort of HIV-1-infected patients
    Chanem, Khalil G.
    Moore, Richard D.
    Rompalo, Anne M.
    Erbelding, Emily J.
    Zenilman, Jonathan M.
    Gebo, Kelly A.
    [J]. AIDS, 2008, 22 (10) : 1145 - 1151
  • [42] Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women
    Villani, P.
    Floridia, M.
    Pirillo, M. F.
    Cusato, M.
    Tamburrini, E.
    Cavaliere, A. F.
    Guaraldi, G.
    Vanzini, C.
    Molinari, A.
    degli Antoni, A.
    Regazzi, M.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) : 309 - 315
  • [43] Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women
    Kosel, BW
    Beckerman, KP
    Hayashi, S
    Homma, M
    Aweeka, FT
    [J]. AIDS, 2003, 17 (08) : 1195 - 1199
  • [44] Population pharmacokinetics of enfuvirtide in HIV-1-infected pediatric patients over 48 weeks of treatment
    Zhang, Xiaoping
    Lin, Tiffany
    Bertasso, Anne
    Evans, Claire
    Dorr, Albert
    Kolis, Stanley J.
    Salgo, Miklos
    Patel, Indravadan
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (04): : 510 - 517
  • [45] Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women
    Izurieta, P.
    Kakuda, T. N.
    Feys, C.
    Witek, J.
    [J]. HIV MEDICINE, 2011, 12 (04) : 257 - 258
  • [46] Abacavir and Metabolite Pharmacokinetics in HIV-1-Infected Children and Adolescents
    Cross, Shane J.
    Rodman, John H.
    Lindsey, Jane C.
    Robbins, Brian L.
    Rose, Charles H.
    Yuen, Geoffrey J.
    D'Angelo, Lawrence J.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (01) : 54 - 59
  • [47] Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients
    Jansen, A.
    Colbers, E. P. H.
    van der Ven, A. J. A. M.
    Richter, C.
    Rockstroh, J. K.
    Wasmuth, J. C.
    van Luin, M.
    Burger, D. M.
    [J]. HIV MEDICINE, 2013, 14 (07) : 449 - 452
  • [48] CYTOMEGALO-VIRUS INFECTION IN HIV-1-INFECTED INDIVIDUALS
    SUTTMANN, U
    GERDELMANN, R
    WILLERS, H
    [J]. ZENTRALBLATT FUR BAKTERIOLOGIE MIKROBIOLOGIE UND HYGIENE SERIES A-MEDICAL MICROBIOLOGY INFECTIOUS DISEASES VIROLOGY PARASITOLOGY, 1988, 269 (01): : 118 - 118
  • [49] Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism
    Saitoh, Akihiko
    Fletcher, Courtney V.
    Brundage, Richard
    Alvero, Carmelita
    Fenton, Terrence
    Hsia, Karen
    Spector, Stephen A.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (03) : 280 - 285
  • [50] Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically suppressed HIV-1-infected adolescents
    Jantarabenjakul, Watsamon
    Anugulruengkitt, Suvaporn
    Kasipong, Naruporn
    Thammajaruk, Narukjaporn
    Sophonphan, Jiratchaya
    Bunupuradah, Torsak
    Cressey, Tim R.
    Colbers, Angela
    Burger, David M.
    Phongsamart, Wanatpreeya
    Puthanakit, Thanyawee
    Pancharoen, Chitsanu
    [J]. ANTIVIRAL THERAPY, 2018, 23 (03) : 259 - 265
12345